These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 19516001

  • 1. Doxycycline-mediated inhibition of choroidal neovascularization.
    Samtani S, Amaral J, Campos MM, Fariss RN, Becerra SP.
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5098-106. PubMed ID: 19516001
    [Abstract] [Full Text] [Related]

  • 2. Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization.
    Amaral J, Becerra SP.
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1318-26. PubMed ID: 19850839
    [Abstract] [Full Text] [Related]

  • 3. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia.
    Notari L, Miller A, Martínez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP.
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2736-47. PubMed ID: 16043845
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.
    Yu HG, Liu X, Kiss S, Connolly E, Gragoudas ES, Michaud NA, Bulgakov OV, Adamian M, DeAngelis MM, Miller JW, Li T, Kim IK.
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2599-605. PubMed ID: 18296663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting immune privilege to prevent pathogenic neovascularization.
    Roychoudhury J, Herndon JM, Yin J, Apte RS, Ferguson TA.
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3560-6. PubMed ID: 20164456
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.
    Yan H, Cui J, Wang Y, Yu Y.
    Ophthalmic Res; 2013 Jul; 49(2):81-9. PubMed ID: 23257710
    [Abstract] [Full Text] [Related]

  • 19. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
    Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y.
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.